trismik/FinRAG huggingface dataset:
Share-Based Compensation
The following table shows a summary of share-based compensation expense included in the Consolidated Statements of Operations during the periods presented (in thousands):
Amounts presented above include share-based compensation expense of $0.8 million for fiscal year 2017, which is recorded as discontinued operations related to employees of our Compute business.
As of September 27, 2019, the total unrecognized compensation costs related to outstanding stock options, restricted stock awards and units including awards with time-based, performance-based, and market-based vesting was $47.0 million, which we expect to recognize over a weighted-average period of 2.9 years.

Fiscal Years
2019
2018
2017
Cost of revenue
$2,936
$3,869
$3,189
Research and development
8,551
13,448
10,565
Selling, general and administrative
12,305
14,620
22,581
Total
$23,792
$31,937
$36,335


Question: Analyse this data from a financial earnings document. What is the change in the Selling, general and administrative expense from 2018 to 2019?
Choices:
26925
-6069
-1143
-10276
-2315
Correct choice index: 4
Non-Operating Income, net: Non-operating income, net consists primarily of interest income, net foreign currency exchange losses, the noncontrolling interests in the net profits of our majority-owned subsidiaries (primarily Oracle Financial Services Software Limited and Oracle Corporation Japan) and net other income, including net recognized gains and losses related to all of our investments, net unrealized gains and losses related to the small portion of our investment portfolio related to our deferred compensation plan, net unrealized gains and losses related to certain equity securities and non-service net periodic pension income (losses).
On a constant currency basis, our non-operating income, net decreased in fiscal 2019 compared to fiscal 2018 primarily due to decreases in other income, net in fiscal 2019 , which was primarily attributable to realized gains on the sale of certa in marketable securities during fiscal 2018 , and lower interest income in fiscal 2019 primarily due to lower average cash, cash equivalent and marketable securities balances during fiscal 2019 .

Year Ended May 31,
Percent Change
(Dollars in millions)
2019
Actual
Constant
2018
Interest income
$1,092
-9%
-9%
$1,203
Foreign currency losses, net
(111)
50%
62%
(74)
Noncontrolling interests in income
(152)
12%
12%
(135)
Other income, net
(14)
-107%
-42%
191
Total non-operating income, net
$815
-31%
-31%
$1,185


Question: Analyse this data from a financial earnings document. How much was the average interest income in 2018 and 2019?
Choices:
546.1
1147.5
55.5
2.1
-55.5
Correct choice index: 1
Proofpoint, Inc. Notes to Consolidated Financial Statements (Continued) (dollars and share amounts in thousands, except per share amounts)
Per the terms of the share purchase agreement, unvested stock options and unvested restricted stock units held by Meta Networks employees were canceled and exchanged for the Company’s unvested stock options and unvested restricted stock units, respectively. The fair value of $184 of these unvested awards was attributed to pre-combination services and was included in consideration transferred. The fair value of $12,918 was allocated to post-combination services. The unvested awards are subject to the recipient’s continued service with the Company, and $12,918 will be recognized ratably as stock-based compensation expense over the required remaining service period.
Also, as part of the share purchase agreement, the unvested restricted shares of certain employees of Meta Networks were exchanged into the right to receive $7,827 of deferred cash consideration and 72 shares of the Company’s common stock that were deferred with the fair value of $8,599. The deferred cash consideration was presented as restricted cash on the Company’s consolidated balance sheet as of December 31, 2019. The deferred cash consideration of $7,596 and the deferred stock $8,338 (see Note 11 “Equity Award Plans”) were allocated to post-combination expense and were not included in the purchase price. The deferred cash consideration and deferred shares are subject to forfeiture if employment terminates prior to the lapse of the restrictions, and their fair value is expensed as compensation and stock-based compensation expense over the three-year vesting period.
The Cost to Recreate Method was used to value the acquired developed technology asset. Management applied judgment in estimating the fair value of this intangible asset, which involved the use of significant assumptions such as the cost and time to build the acquired technology, developer’s profit and rate of return.
The following table summarizes the fair values of tangible assets acquired, liabilities assumed, intangible assets and goodwill:

Fair value
Estimated Useful Life
(in years)
Current assets
$356
N/A
Fixed assets
68
N/A
Core/developed technology
21,000
3
Deferred tax liability, net
(1,854)
N/A
Other liabilities
(671)
N/A
Goodwill
85,869
Indefinite
$104,768


Question: Analyse this data from a financial earnings document. What is the total estimated fair value of all assets?
Choices:
424
435
64445
21424000000
21424
Correct choice index: 4
the company granted 1020 performance shares .
the vesting of these shares is contingent on meeting stated goals over a performance period .
beginning with restricted stock grants in september 2010 , dividends are accrued on restricted class a common stock and restricted stock units and are paid once the restricted stock vests .
the following table summarizes restricted stock and performance shares activity for 2010 : number of shares weighted average grant date fair value .

Number of Shares
Weighted Average Grant Date Fair Value
Outstanding at December 31, 2009
116,677
$280
Granted
134,245
275
Vested
(34,630)
257
Cancelled
(19,830)
260
Outstanding at December 31, 2010
196,462
283

the total fair value of restricted stock that vested during the years ended december 31 , 2010 , 2009 and 2008 , was $ 10.3 million , $ 6.2 million and $ 2.5 million , respectively .
eligible employees may acquire shares of cme group 2019s class a common stock using after-tax payroll deductions made during consecutive offering periods of approximately six months in duration .
shares are purchased at the end of each offering period at a price of 90% ( 90 % ) of the closing price of the class a common stock as reported on the nasdaq .
compensation expense is recognized on the dates of purchase for the discount from the closing price .
in 2010 , 2009 and 2008 , a total of 4371 , 4402 and 5600 shares , respectively , of class a common stock were issued to participating employees .
these shares are subject to a six-month holding period .
annual expense of $ 0.1 million for the purchase discount was recognized in 2010 , 2009 and 2008 , respectively .
non-executive directors receive an annual award of class a common stock with a value equal to $ 75000 .
non-executive directors may also elect to receive some or all of the cash portion of their annual stipend , up to $ 25000 , in shares of stock based on the closing price at the date of distribution .
as a result , 7470 , 11674 and 5509 shares of class a common stock were issued to non-executive directors during 2010 , 2009 and 2008 , respectively .
these shares are not subject to any vesting restrictions .
expense of $ 2.4 million , $ 2.5 million and $ 2.4 million related to these stock-based payments was recognized for the years ended december 31 , 2010 , 2009 and 2008 , respectively. .

Question: Analyse this data from a financial earnings document. what was the sum of the total fair value of restricted stock that vested during 2008 and 2010 in millions
Choices:
19.0
217.5
128.8
14
19000000
Correct choice index: 0
ITEM 6. SELECTED FINANCIAL DATA
In December 2016, we acquired the 67% remaining interest in Inotera and began consolidating Inotera's operating results. In the periods presented above through December 2016, Inotera sold DRAM products exclusively to us through supply agreements. The cash paid for the Inotera Acquisition was funded, in part, with a term loan of 80 billion New Taiwan dollars and $986 million from the sale of 58 million shares of our common stock. See "Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Acquisition of Inotera."

2019
2018
2017
2016
2015
(in millions, except per share amounts)
Revenue
$23,406
$30,391
$20,322
$12,399
$16,192
Gross margin
10,702
17,891
8,436
2,505
5,215
Operating income
7,376
14,994
5,868
168
2,998
Net income (loss)
6,358
14,138
5,090
(275)
2,899
Net income (loss) attributable to Micron
6,313
14,135
5,089
(276)
2,899
Diluted earnings (loss) per share
5.51
11.51
4.41
(0.27)
2.47
Cash and short-term investments
7,955
6,802
5,428
4,398
3,521
Total current assets
16,503
16,039
12,457
9,495
8,596
Property, plant, and equipment
28,240
23,672
19,431
14,686
10,554
Total assets
48,887
43,376
35,336
27,540
24,143
Total current liabilities
6,390
5,754
5,334
4,835
3,905
Long-term debt
4,541
3,777
9,872
9,154
6,252
Total Micron shareholders' equity
35,881
32,294
18,621
12,080
12,302
Noncontrolling interests in subsidiaries
889
870
849
848
937
Total equity
36,770
33,164
19,470
12,928
13,239


Question: Analyse this data from a financial earnings document. What is the gross profit margin of the company in 2015?
Choices:
1
3.1
0.33
0.32
0.27
Correct choice index: 3
REVENUES BY SERVICES AND PRODUCTS
The following table presents our revenues disaggregated by type of services and products.
(1) Our service revenues are generally recognized over time.
(2) Our product revenues are generally recognized at a point in time.

FOR THE YEAR ENDED DECEMBER 31
2019
2018
Services (1)
Wireless
6,427
6,269
Wireline data
7,684
7,466
Wireline voice
3,564
3,782
Media
2,811
2,677
Other wireline services
251
247
Total services
20,737
20,441
Products (2)
Wireless
2,660
2,497
Wireline data
519
466
Wireline equipment and other
48
64
Total products
3,227
3,027
Total operating revenues
23,964
23,468


Question: Analyse this data from a financial earnings document. What is the average annual Total services?
Choices:
11
20589
1
2
6
Correct choice index: 1
underlying physical transaction occurs .
we have not qualified commodity derivative instruments used in our osm or rm&t segments for hedge accounting .
as a result , we recognize in net income all changes in the fair value of derivative instruments used in those operations .
open commodity derivative positions as of december 31 , 2008 and sensitivity analysis at december 31 , 2008 , our e&p segment held open derivative contracts to mitigate the price risk on natural gas held in storage or purchased to be marketed with our own natural gas production in amounts that were in line with normal levels of activity .
at december 31 , 2008 , we had no significant open derivative contracts related to our future sales of liquid hydrocarbons and natural gas and therefore remained substantially exposed to market prices of these commodities .
the osm segment holds crude oil options which were purchased by western for a three year period ( january 2007 to december 2009 ) .
the premiums for the purchased put options had been partially offset through the sale of call options for the same three-year period , resulting in a net premium liability .
payment of the net premium liability is deferred until the settlement of the option contracts .
as of december 31 , 2008 , the following put and call options were outstanding: .

Option Expiration Date
2009
Option Contract Volumes<i>(Barrels per day)</i>:
Put options purchased
20,000
Call options sold
15,000
Average Exercise Price<i>(Dollars per barrel</i>):
Put options
$50.50
Call options
$90.50

in the first quarter of 2009 , we sold derivative instruments at an average exercise price of $ 50.50 which effectively offset the open put options for the remainder of 2009 .
at december 31 , 2008 , the number of open derivative contracts held by our rm&t segment was lower than in previous periods .
starting in the second quarter of 2008 , we decreased our use of derivatives to mitigate crude oil price risk between the time that domestic spot crude oil purchases are priced and when they are actually refined into salable petroleum products .
instead , we are addressing this price risk through other means , including changes in contractual terms and crude oil acquisition practices .
additionally , in previous periods , certain contracts in our rm&t segment for the purchase or sale of commodities were not qualified or designated as normal purchase or normal sales under generally accepted accounting principles and therefore were accounted for as derivative instruments .
during the second quarter of 2008 , as we decreased our use of derivatives , we began to designate such contracts for the normal purchase and normal sale exclusion. .

Question: Analyse this data from a financial earnings document. for option expiration dates in 2009 , what was the average option contract volumes ( barrels per day ) for put options purchased and \\ncall options sold?
Choices:
17500
0
17500.0
1
386.7
Correct choice index: 2
The Company’s estimated future benefit payments as of December 31, 2019 are as follows:
The Company has certain defined contribution plans, which accrue benefits for employees on a pro-rata basis during their employment period based on their individual salaries. The Company’s accrued benefits related to defined contribution pension plans of $20 million as of December 31, 2019 and $18 million as of December 31, 2018. The annual cost of these plans amounted to approximately $86 million in 2019, $84 million in 2018 and $77 million in 2017.

Years
Pension Benefits
Other Long Term Benefits
2020
32
7
2021
29
7
2022
32
5
2023
41
6
2024
51
9
From 2025 to 2029
272
35


Question: Analyse this data from a financial earnings document. What is the average benefit payments for 2021 to 2022?
Choices:
61
884.5
30.5
1.9
-30.5
Correct choice index: 2
Stock-based compensation expense is recognized in the Company’s consolidated statements of operations and includes compensation expense for the stock-based compensation awards granted or modified subsequent to January 1, 2006, based on the grant date fair value estimated in accordance with the provisions of the amended authoritative guidance. The impact on the Company’s results of operations of recording stock-based compensation expense for fiscal years 2019, 2018, and 2017 was as follows (in thousands):
No stock-based compensation was capitalized or included in inventories at the end of 2019, 2018 and 2017.

Fiscal Years
2019
2018
2017
Cost of revenue
$78
$129
$121
Research and development
2,242
760
614
Selling, general and administrative
824
1,012
706
Total costs and expenses
$3,144
$1,901
$1,441


Question: Analyse this data from a financial earnings document. What is the average stock-based compensation for research and development in 2018 and 2019?
Choices:
380
2
687
1501
-1501
Correct choice index: 3
as of february 15 , 2008 , there were 138311810 shares of our common stock outstanding held by approximately 2979 stockholders of record .
dividends and distributions we pay regular quarterly dividends to holders of our common stock .
on february 13 , 2008 , our board of directors declared the first quarterly installment of our 2008 dividend in the amount of $ 0.5125 per share , payable on march 28 , 2008 to stockholders of record on march 6 , 2008 .
we expect to distribute 100% ( 100 % ) or more of our taxable net income to our stockholders for 2008 .
our board of directors normally makes decisions regarding the frequency and amount of our dividends on a quarterly basis .
because the board considers a number of factors when making these decisions , we cannot assure you that we will maintain the policy stated above .
please see 201ccautionary statements 201d and the risk factors included in part i , item 1a of this annual report on form 10-k for a description of other factors that may affect our distribution policy .
our stockholders may reinvest all or a portion of any cash distribution on their shares of our common stock by participating in our distribution reinvestment and stock purchase plan , subject to the terms of the plan .
see 201cnote 16 2014capital stock 201d of the notes to consolidated financial statements included in part ii , item 8 of this annual report on form 10-k .
director and employee stock sales certain of our directors , executive officers and other employees have adopted and may , from time to time in the future , adopt non-discretionary , written trading plans that comply with rule 10b5-1 under the exchange act , or otherwise monetize their equity-based compensation .
stock repurchases the table below summarizes repurchases of our common stock made during the quarter ended december 31 , 2007 : number of shares repurchased ( 1 ) average price per .

Number of Shares Repurchased (1)
Average Price Per Share
October 1 through October 31
—
—
November 1 through November 30
—
—
December 1 through December 31
14,669
$43.89

( 1 ) repurchases represent shares withheld to pay taxes on the vesting of restricted stock granted to employees. .

Question: Analyse this data from a financial earnings document. prior to the shares repurchased in 2007 , how many shares of common stock were outstanding?
Choices:
29338
138326479
138326479.0
276623620
138311840
Correct choice index: 2
24. EARNINGS PER SHARE
The following table set forth the computation for basic and diluted net income (loss) per share of common stock (in thousands, except per share data):
As of September 27, 2019, we had warrants outstanding which were reported as a liability on the consolidated balance sheet. During fiscal years 2019 and 2018, we recorded gains of $0.8 million and $27.6 million, respectively, associated with adjusting the fair value of the warrants, in the Consolidated Statements of Operations primarily as a result of declines in our stock price.
When calculating earnings per share we are required to adjust for the dilutive effect of outstanding common stock equivalents, including adjustment to the numerator for the dilutive effect of contracts that must be settled in common stock. During the fiscal year ended September 27, 2019, we excluded the effects of the warrant gain and the 214,303 of potential shares of common stock issuable upon exercise of warrants as the inclusion would be anti-dilutive.
During the fiscal year ended September 28, 2018, we adjusted the numerator to exclude the warrant gain $27.6 million, and we also adjusted the denominator for the dilutive effect of the incremental warrant shares of 569,667 under the treasury stock method. For the fiscal years 2018, the table above excludes the effects of 375,940 shares of potential shares of common stock issuable upon exercise of stock options, restricted stock and restricted stock units as the inclusion would be anti-dilutive.
The table excludes the effects of 386,552 and 1,877,401 shares for fiscal years 2019 and 2017, respectively, of potential shares of common stock issuable upon exercise of stock options, restricted stock, restricted stock units and warrants as the inclusion would be anti-dilutive.

Fiscal Years
2019
2018
2017
Numerator:     
Loss from continuing operations
$(383,798)
$(133,762)
$(150,416)
Loss from discontinued operations
—
(6,215)
(19,077)
Net loss
(383,798)
(139,977)
(169,493)
Warrant liability gain
—
(27,646)
—
Net loss attributable to common stockholders
$(383,798)
$(167,623)
$(169,493)
Denominator:     
Weighted average common shares outstanding-basic
65,686
64,741
60,704
Dilutive effect of warrants
—
570
—
Weighted average common shares outstanding-diluted
65,686
65,311
60,704
Common stock earnings per share-basic:     
Continuing operations
$(5.84)
$(2.07)
$(2.48)
Discontinued operations
—
(0.10)
(0.31)
Net common stock earnings per share-basic
$(5.84)
$(2.16)
$(2.79)
Common stock earnings per share-diluted:
Continuing operations
$(5.84)
$(2.47)
$(2.48)
Discontinued operations
—
(0.10)
(0.31)
Net common stock earnings per share-diluted
$(5.84)
$(2.57)
$(2.79)


Question: Analyse this data from a financial earnings document. What was the average Net loss for 2017 to 2019?
Choices:
0
231089.33
-4.09
2310.89
-248483.15
Correct choice index: 1
1. THE BUSINESS
Maple Leaf Foods Inc. (“Maple Leaf Foods” or the "Company") is a producer of food products under leading brands including Maple
Leaf®, Maple Leaf Prime®, Schneiders®, Mina®, Greenfield Natural Meat Co.®, Swift®, Lightlife®, and Field Roast Grain Meat Co.™
The Company's portfolio includes prepared meats, ready-to-cook and ready-to-serve meals, valued-added fresh pork and poultry and
plant protein products. The address of the Company's registered office is 6985 Financial Dr. Mississauga, Ontario, L5N 0A1, Canada.
The Company employs approximately 13,000 people and does business primarily in Canada, the U.S. and Asia. The Company's shares trade on the Toronto Stock Exchange (MFI).
1. THE BUSINESS Maple Leaf Foods Inc. (“Maple Leaf Foods” or the "Company") is a producer of food products under leading brands including Maple Leaf®, Maple Leaf Prime®, Schneiders®, Mina®, Greenfield Natural Meat Co.®, Swift®, Lightlife®, and Field Roast Grain Meat Co.™ The Company's portfolio includes prepared meats, ready-to-cook and ready-to-serve meals, valued-added fresh pork and poultry and plant protein products. The address of the Company's registered office is 6985 Financial Dr. Mississauga, Ontario, L5N 0A1, Canada. The Company employs approximately 13,000 people and does business primarily in Canada, the U.S. and Asia. The Company's shares trade on the Toronto Stock Exchange (MFI).
Sales for 2019 were $3,941.5 million compared to $3,495.5 million last year, an increase of 12.8%. Excluding acquisitions, sales increased 5.2%, driven by favourable pricing, mix and volume in meat protein and accelerated growth in plant protein of 23.6%.
Net earnings for 2019 were $74.6 million ($0.60 per basic share) compared to $101.3 million ($0.81 per basic share) last year. Strong commercial performance and favourable resolution of income tax audits were more than offset by strategic investments in plant protein to drive top line growth and heightened volatility in hog prices. Net earnings were negatively impacted by $12.1 million due to non-cash fair value changes in biological assets and derivative contracts, which are excluded in the calculation of Adjusted Operating Earnings below.
Adjusted Operating Earnings for 2019 were $145.4 million compared to $215.6 million last year, and Adjusted Earnings per Share for
2019 were $0.68 compared to $1.22 last year due to similar factors as noted above.
For further discussion on key metrics and a discussion of results by operating segment, refer to the section titled Operating Review
starting on page 3 of this document.

Twelve months ended December 31,
($ millions except earnings per share)
2019
2018
% Change
Sales
$3,941.5
$3,495.5
12.8 %
Net Earnings
$74.6
$101.3
(26.4)%
Basic Earnings per Share
$0.60
$0.81
(25.9)%
Adjusted Operating Earnings(i)
$145.4
$215.6
(32.6)%
Adjusted Earnings per Share(i)
$0.68
$1.22
(44.3)%


Question: Analyse this data from a financial earnings document. How many outstanding shares does the company has in 2019?
Choices:
-124.33
124.33
75.2
168.83
316.1
Correct choice index: 1
AMERICAN TOWER CORPORATION AND SUBSIDIARIES NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Tabular amounts in millions, unless otherwise disclosed)
8. ACCRUED EXPENSES
Accrued expenses consisted of the following:

As of
December 31, 2019
December 31, 2018
Accrued property and real estate taxes
$198.1
$169.7
Accrued pass-through costs
74.2
71.2
Amounts payable to tenants
77.9
93.5
Accrued rent
75.6
61.4
Payroll and related withholdings
102.4
90.4
Accrued construction costs
27.8
41.5
Accrued income tax payable
55.2
57.9
Other accrued expenses
347.0
362.7
Accrued expenses
$958.2
$948.3


Question: Analyse this data from a financial earnings document. What is the sum of the three highest expenses in 2019?
Choices:
1258.7
300.5
551.8
355.7
647.5
Correct choice index: 4